BiotechTube
Aizon

Aizon

Barcelona, Spain· Est.
aizon.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $28M

Overview

Aizon is a private, revenue-generating AI/ML software company focused on optimizing biopharmaceutical manufacturing. Its platform, delivered as a service, unifies manufacturing data and provides predictive analytics to solve operational challenges like yield optimization, batch release acceleration, and root cause analysis. With a proven implementation model promising results in weeks, Aizon serves major clients like Grifols and Curia, and is backed by investors including Crosslink Capital and Atlantic Bridge.

AI / Machine Learning

Technology Platform

Cloud-native, GxP-compliant AI/ML SaaS platform that unifies manufacturing data ("Unify") and provides predictive analytics ("Predict") for biopharma production optimization, quality assurance, and compliance.

Funding History

2
Total raised:$28M
Series B$20M
Series A$8M

Opportunities

The global push for biopharma manufacturing efficiency, regulatory encouragement of advanced analytics, and the complexity of new biologic modalities create a large and growing market.
Aizon can expand within existing enterprise clients and into high-growth areas like cell and gene therapy manufacturing.

Risk Factors

Competition from large industrial automation incumbents and the challenge of scaling a domain-expert-intensive implementation model.
Regulatory risk associated with AI-driven decisions in GxP environments and potential cultural resistance to adoption within conservative pharma organizations.

Competitive Landscape

Aizon competes with large industrial software and MES vendors (e.g., Siemens, Werum) adding AI features, and with broader data analytics platforms. Its key differentiator is a deep, consulting-led focus on pharma-specific GxP use cases and a promise of rapid, tangible ROI.

More companies in AI / Machine Learning →More companies in Spain →